Home Healthcare Market

Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), & Region - Global Forecast to 2026

Report Code: MD 1160 Nov, 2021, by marketsandmarkets.com

[438 Pages Report] The global home healthcare market size is projected to reach USD 298.2 billion by 2026 from USD 198.9 billion in 2021, at a CAGR of 8.4% during the forecast period. Rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements of home care devices.

On the other hand, changing reimbursement policies, limited insurance coverage, and concerns regarding patient safety are factors limiting the growth of the market to a certain extent. The growing popularity of telehealth and untapped developing regions present significant growth opportunities for players in the home healthcare market.

Home Healthcare Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the home healthcare market

The COVID-19 pandemic has a mixed impact on the home healthcare market. As the home healthcare market consists of products and services, both have different effects. COVID-19 would positively impact few home healthcare monitoring products such as blood glucose monitors, blood pressure monitors, pulse oximeters, and temperature monitors.

Due to the coronavirus pandemic, one might be under the assumption that the home healthcare service industry would be booming because home healthcare providers would be able to treat the vulnerable and elderly population in the comfort of their homes. However, the scenario is different. There have been many home healthcare agencies and providers who have reported a decline in the business.  However, this downturn in the home healthcare industry is predicted to be for a while, as the business will pick up at a faster pace in the coming future as more people are recovering from COVID-19.

Global Home Healthcare Market Dynamics

DRIVER: Rising aging population, high incidence of chronic diseases, and need to expand home healthcare access

The growth of the aging population segment will boost the demand for healthcare and significantly increase the burden on governments and health systems as the aging population is more prone to chronic diseases. This will prove favorable to the market for home healthcare, which can enhance the overall reach of and access to healthcare while reducing unnecessary visits, hospital admissions & readmissions, and the time and costs involved in traveling to meet healthcare professionals.

RESTRAINT: Patient safety concerns

In home care, the nurse-physician association involves lesser face-to-face contact, and the nurse is responsible for making assessments and communicating findings. This factor affects the degree of patient safety and outcomes. Another distinguishing characteristic of home healthcare is that clinicians offer medical care to each patient in a unique setting. However, there may be situational variables that present risks to patients that may be difficult to remove. Hospitals have well-equipped environmental safety departments to take care of such instances.

OPPORTUNITY: Growing demand for home care therapeutic devices

Rising healthcare costs have resulted in increased patient preference for home-based treatments. Products such as nebulizers, ventilators, and continuous positive airway pressure (CPAP) devices are used by patients to treat, diagnose, and monitor various respiratory diseases in-home care settings. These devices, along with home care services, provide cost-effective healthcare to patients.

The rapid growth in the global geriatric population, rising incidence of chronic diseases (including COPD and asthma), and the cost advantages of home care devices and services (compared to hospital visits) are the key factors driving the growth of the home healthcare market. The high growth potential in emerging markets, healthcare decentralization, and the evolution of miniaturized devices are some of the major factors that are expected to provide significant growth opportunities to the players operating in the respiratory home healthcare market. Owing to the rising healthcare costs, a large number of patients suffering from chronic respiratory diseases prefer to undergo treatments in home care settings. This trend is expected to increase the demand for products, including nebulizers, ventilators, and CPAP devices, as they are used by patients to treat, diagnose, and monitor a variety of respiratory diseases in home care settings.

CHALLENGE: Shortage of home care workers

Home healthcare is a booming market, with increasing demand for home care providers/workers. According to the employment projections of the US Bureau of Labor Statistics, during 2014-2024, home healthcare occupations such as personal care aides and home health aides ranked among the top 10 in the list. Also, the demand for home health aides and personal care aides is estimated to be 2.9 million between 2016-2026. Hence, home healthcare providers need to find approximately 2.9 million heads to keep with the rising demand (Source: US Bureau of Labor Statistics).

The skilled nursing care services segment dominated the home healthcare services market in 2020.

Based on services, the global home healthcare market is segmented into rehabilitation services, infusion therapy services, unskilled care services, respiratory therapy services, pregnancy care services, skilled nursing services, and hospice and palliative care services. Skilled nursing services accounted for the largest share of the home healthcare services market in 2020. Skilled medical care in home settings can provide a comforting solution over residing in a hospital, nursing home, or an assisted living community. The favorable insurance coverage for skilled nursing services is expected to support the growth of this market during the forecast period.

The diabetes segment to witness the highest CAGR during the forecast period.

Based on indication, the global home healthcare market is segmented into cancer, respiratory diseases, mobility disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications. The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing number of diabetic patients. Monitoring blood sugar at home helps arrive at an overall diabetes treatment plan and aids in managing the medications for blood sugar, diet, and exercise.

Home Healthcare Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for home healthcare in 2020.

The home healthcare market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America was the largest regional segment of the overall market, followed by Europe. The large share of North America in the global market is attributed to the rising prevalence of chronic conditions, high healthcare expenditure, high disposable income, the increasing overall geriatric population, high disposable income, and superior healthcare infrastructure.

Key Market Players

The prominent players operating in this market include Fresenius SE & Co. KGaA (Germany), GE Healthcare (US), Linde plc (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Amedisys (US), ResMed (US), and LHC Group, Inc. (US)

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2018–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD)

Segments covered

Product, service, indication, and region

Geographies covered

North America, Europe, Asia Pacific, and the Rest of the World

Companies covered

Fresenius SE & Co. KGaA (Germany), GE Healthcare (US), Linde plc (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), A&D Company (Japan), BAYADA Home Health Care (US), Invacare Corporation (US), Abbott (US), Amedisys (US), ResMed (US), LHC Group, Inc. (US), OMRON Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Drive DeVilbiss Healthcare (US), Hamilton Medical (Switzerland), Sunrise Medical (Germany), Roma Medical (UK), Caremax Rehabilitation Equipment Co., Ltd(China), Vitalograph (UK), advita Pflegedienst GmbH (Germany), RENAFAN GmbH (Germany), ADMR (France), Apex Medical Corporation (Taiwan), CONTEC MEDICAL SYSTEMS CO., LTD (China), and Lφwenstein Medical Technology GmbH + Co. KG. (Germany).

This report categorizes the home healthcare market into the following segments and subsegments:

By Product

  • Testing, Screening, & Monitoring Products
    • Blood Glucose Monitors
    • Blood Pressure Monitors
    • Pulse Oximeters
    • Peak Flow Meters
    • Heart Rate Monitors
    • Fetal Monitoring Devices
    • HIV Test Kits
    • Home Sleep Testing Devices
    • Coagulation Monitoring Products
    • Ovulation and Pregnancy Test Kits
    • Holter and Event Monitors
    • Cholesterol Monitoring Devices
    • Colon Cancer Test Kits
    • Home Hemoglobin A1c Test Kits
    • Drug and Alcohol Test Kits
    • ECG/EKG Devices
    • EEG Devices
    • Temperature Monitors
    • Hearing Aids
    • Activity Monitors & Wristbands
  • Therapeutic Products
    • Oxygen Delivery Systems
    • Nebulizers
    • Ventilators
    • Sleep Apnea Therapeutic Devices
    • Wound Care Products
    • IV Equipment
    • Dialysis Equipment
    • Insulin Delivery Devices
    • Inhalers
    • Other Therapeutic Products (ostomy devices, automated external defibrillators (AEDs))
  • Mobility Care Products
    • Wheelchairs
    • Walkers & Rollators
    • Mobility Scooters
    • Canes
    • Crutches

By Service

  • Skilled Nursing Services
  • Rehabilitation Therapy Services
  • Hospice and Palliative Care Services
  • Unskilled Care Services
  • Respiratory Therapy Services
  • Infusion Therapy Services
  • Pregnancy Care Services

By Indication

  • Cardiovascular Disorders & Hypertension
  • Diabetes
  • Respiratory Diseases
  • Pregnancy
  • Mobility Disorders
  • Hearing Disorders
  • Cancer
  • Wound Care
  • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World

Recent Developments

  • In 2021, Invacare introduced the AVIVA STORM RX, a next-generation rear-wheel drive power wheelchair and next-generation Alber e-motion power assist device.
  • In 2021, Abbott’s BinaxNOW COVID-19 rapid self-test kit requires no specialized instrument and can be used at home with a first-of-its-kind complementary app called NAVICA.
  • In 2021, BAYADA Home Health Care announced partnership with VCU Health System would strengthen in-home health and hospice care in the Richmond metropolitan area of the US.
  • In 2021, BAYADA Home Health Care announced partnership with Autism Society of Hawaii (US) new partnership would offer services throughout Hawaii for individuals with autism and other developmental disabilities at home, school, in the community, and in their centers.
  • In 2020, Lincare, a subsidiary of Linde, offers home respiratory care in the US. In response to the COVID-19 pandemic, the company offers in-home services to COVID-19 vulnerable patients. It is also helping to ease the burden on hospitals by transferring respiratory patients and others from in-patient to in-home care.
  • LHC Group Inc (US) entered into a joint venture agreement with University Health Care System (US). This joint venture agreement was aimed to strengthen home health and hospice services across eight cities in Georgia and South Carolina.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 49)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
          TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 54)
    2.1 RESEARCH DATA
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Primary sources
                    2.1.2.2 Key data from primary sources
                    2.1.2.3 Key industry insights
                    2.1.2.4 Breakdown of primary interviews: By company type, designation,  and region
    2.2 MARKET SIZE ESTIMATION
          FIGURE 2 REVENUE SHARE ANALYSIS ILLUSTRATION: F. HOFFMANN-LA ROCHE LTD.
          FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF HOME HEALTHCARE PRODUCTS AND SERVICES
          FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
          FIGURE 5 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION
          FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 LIMITATIONS
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
    2.7 RISK ASSESSMENT
          TABLE 2 RISK ASSESSMENT: HOME HEALTHCARE MARKET
    2.8 COVID-19 HEALTH ASSESSMENT
    2.9 COVID-19 ECONOMIC ASSESSMENT
    2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
          FIGURE 7 CRITERIA IMPACTING THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY (Page No. - 68)
    FIGURE 9 HOME HEALTHCARE MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
    FIGURE 10 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
    FIGURE 11 HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION)
    FIGURE 12 HOME HEALTHCARE MARKET, BY INDICATION, 2021 VS. 2026 (USD BILLION)
    FIGURE 13 HOME HEALTHCARE MARKET, BY REGION, 2021 VS. 2026 (USD BILLION)

4 PREMIUM INSIGHTS (Page No. - 72)
    4.1 HOME HEALTHCARE MARKET OVERVIEW
          FIGURE 14 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH  DURING THE FORECAST PERIOD
    4.2 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET,  BY TYPE, 2021 VS. 2026 (USD MILLION)
          FIGURE 15 INHALERS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
    4.3 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY MOBILITY  CARE PRODUCT AND COUNTRY (2020)
          FIGURE 16 WHEELCHAIRS DOMINATED THE ASIA PACIFIC HOME HEALTHCARE MARKET IN 2020
    4.4 HOME HEALTHCARE MARKET, BY SERVICE, 2021–2026
          FIGURE 17 INFUSION THERAPY SERVICES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021-2026)
    4.5 HOME HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 18 JAPAN IS THE FASTEST-GROWING MARKET FOR HOME HEALTHCARE

5 MARKET OVERVIEW (Page No. - 76)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 19 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rapid growth in the elderly population and the rising incidence of chronic diseases
                                TABLE 3 OVERVIEW OF THE GERIATRIC POPULATION (MILLION)
                                FIGURE 20 GERIATRIC POPULATION, BY COUNTRY, 2010 VS. 2019  (% OF THE TOTAL POPULATION)
                    5.2.1.2 Rising R&D investments resulting in technologically advanced devices
                                TABLE 4 PRODUCT LAUNCHES
                                FIGURE 21 R&D EXPENDITURE (% OF TOTAL REVENUE), BY KEY PLAYER, 2019. VS 2020
                    5.2.1.3 Growing need for cost-effective healthcare delivery due to the increasing healthcare costs
                    5.2.1.4 Outbreak of the COVID-19 pandemic
           5.2.2 RESTRAINTS
                    5.2.2.1 Changing reimbursement policies
                    5.2.2.2 Limited insurance coverage
                    5.2.2.3 Patient safety concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising focus on telehealth
                    5.2.3.2 Untapped developing regions
                    5.2.3.3 Growing demand for home care therapeutic devices
                    5.2.3.4 Growing demand for home sleep apnea tests (HSATs)
                    5.2.3.5 Growing preference for home hemodialysis treatment
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of homecare workers
    5.3 RANGES/SCENARIOS
           5.3.1 HOME HEALTHCARE MARKET
                    FIGURE 22 PESSIMISTIC SCENARIO
                    FIGURE 23 OPTIMISTIC SCENARIO
                    FIGURE 24 REALISTIC SCENARIO
    5.4 REGULATORY ANALYSIS
          TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES
           5.4.1 NORTH AMERICA
                    5.4.1.1 US
                                TABLE 6 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA
                                TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                                FIGURE 25 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
                    5.4.1.2 Canada
                                TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                                FIGURE 26 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA
           5.4.2 EUROPE
                    FIGURE 27 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES
           5.4.3 ASIA PACIFIC
                    5.4.3.1 Japan
                                TABLE 9 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN
                    5.4.3.2 China
                                TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.4.3.3 India
    5.5 PORTER’S FIVE FORCES ANALYSIS: PULSE OXIMETERS MARKET
           TABLE 11 PORTER’S FIVE FORCES ANALYSIS FOR THE PULSE OXIMETERS MARKET
           5.5.1 THREAT OF NEW ENTRANTS
           5.5.2 THREAT OF SUBSTITUTES
           5.5.3 BARGAINING POWER OF SUPPLIERS
           5.5.4 BARGAINING POWER OF BUYERS
           5.5.5 INTENSITY OF COMPETITIVE RIVALRY
    5.6 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET
           TABLE 12 PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET
           5.6.1 THREAT OF NEW ENTRANTS
           5.6.2 THREAT OF SUBSTITUTES
           5.6.3 BARGAINING POWER OF BUYERS
           5.6.4 BARGAINING POWER OF SUPPLIERS
           5.6.5 DEGREE OF COMPETITION
    5.7 TECHNOLOGY ANALYSIS
    5.8 VALUE CHAIN ANALYSIS
          FIGURE 28 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE
    5.9 SUPPLY CHAIN ANALYSIS
          FIGURE 29 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.10 PATENT ANALYSIS
           5.10.1 PATENT GRANTED TRENDS FOR HOME HEALTHCARE
                     FIGURE 30 PATENT GRANTED TRENDS, JANUARY 2011–NOVEMBER 2021
           5.10.2 JURISDICTION AND TOP APPLICANT ANALYSIS
                     FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PULSE OXIMETER PATENTS, JANUARY 2011—NOVEMBER 2021
    5.11 TRADE ANALYSIS
           TABLE 13 IMPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY,  2016–2020 (USD MILLION)
           TABLE 14 EXPORT DATA FOR HS CODE 901890 - INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY,  2016–2020 (USD MILLION)
    5.12 PRICING ANALYSIS
           TABLE 15 PRICE RANGE FOR HOME CARE DEVICES, BY COUNTRY
           TABLE 16 PRICES OF HEARING AIDS (2021)
    5.13 ECOSYSTEM ANALYSIS
            FIGURE 32 HOME HEALTHCARE DEVICES MARKET: ECOSYSTEM ANALYSIS
           5.13.1 ROLE IN THE ECOSYSTEM
                     FIGURE 33 KEY PLAYERS IN THE HOME HEALTHCARE ECOSYSTEM
    5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR HOME HEALTHCARE PRODUCT MANUFACTURERS OR SERVICE PROVIDERS
                     FIGURE 34 REVENUE SHIFT FOR HOME HEALTHCARE PRODUCTS AND SERVICES
                     TABLE 17 ADJACENT MARKETS AND THEIR CURRENT GROWTH

6 HOME HEALTHCARE MARKET, BY PRODUCT (Page No. - 113)
    6.1 INTRODUCTION
          TABLE 18 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD BILLION)
          TABLE 19 HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD BILLION)
          TABLE 20 HOME HEALTHCARE PRODUCTS MARKET, BY REGION, 2018–2020 (USD BILLION)
          TABLE 21 HOME HEALTHCARE PRODUCTS MARKET, BY REGION, 2021–2026 (USD BILLION)
    6.2 THERAPEUTIC PRODUCTS
          TABLE 22 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 23 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 24 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION, 2018–2020 (USD BILLION)
          TABLE 25 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION, 2021–2026 (USD BILLION)
           6.2.1 DIALYSIS EQUIPMENT
                    6.2.1.1 Dialysis equipment has gained significance due to its improved clinical outcomes and better quality of life for patients
                                TABLE 26 DIALYSIS EQUIPMENT MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 27 DIALYSIS EQUIPMENT MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.2 WOUND CARE PRODUCTS
                    6.2.2.1 Decreased cost and higher convenience and comfort of home care will ensure the growth of this segment
                                TABLE 28 WOUND CARE PRODUCTS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.3 IV EQUIPMENT
                    6.2.3.1 IV equipment facilitates the delivery of antibiotics, fluid replacements, and chemotherapy with accuracy
                                TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 31 IV EQUIPMENT MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.4 SLEEP APNEA THERAPEUTIC DEVICES
                    6.2.4.1 Increasing patient preference for home-based sleep tests to fuel market growth
                                TABLE 32 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 33 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.5 INSULIN DELIVERY DEVICES
                    6.2.5.1 High incidence of diabetes to drive the insulin delivery  devices market
                                TABLE 34 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 35 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.6 OXYGEN DELIVERY SYSTEMS
                    6.2.6.1 Technological advancements in oxygen therapy products to  drive the market
                                TABLE 36 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 37 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.7 INHALERS
                    6.2.7.1 High incidence of asthma is the major factor driving  market growth
                                TABLE 38 INHALERS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 39 INHALERS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.8 NEBULIZERS
                    6.2.8.1 Nebulizers are more effective as compared to oral dosages
                                TABLE 40 NEBULIZERS AVAILABLE IN THE MARKET
                                TABLE 41 NEBULIZERS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 42 NEBULIZERS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.9 VENTILATORS
                    6.2.9.1 Home care ventilators are convenient and can be used in the comfort of the patient’s home
                                TABLE 43 VENTILATORS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 44 VENTILATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.2.10 OTHER THERAPEUTIC PRODUCTS
                     TABLE 45 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION, 2018–2020 (USD MILLION)
                     TABLE 46 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION)
    6.3 TESTING, SCREENING, AND MONITORING PRODUCTS
          TABLE 47 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET,  BY TYPE, 2018–2020 (USD MILLION)
          TABLE 48 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET,  BY TYPE, 2021–2026 (USD MILLION)
          TABLE 49 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET,  BY REGION, 2018–2020 (USD BILLION)
          TABLE 50 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET,  BY REGION, 2021–2026 (USD BILLION)
           6.3.1 BLOOD GLUCOSE MONITORS
                    6.3.1.1 Increasing prevalence of diabetes to drive the market growth
                                TABLE 51 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 52 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.2 HEARING AIDS
                    6.3.2.1 High incidence of hearing impairment to drive the market
                                TABLE 53 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP
                                TABLE 54 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020, BY AGE GROUP (10-YEAR RANGE)
                                TABLE 55 GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP
                                TABLE 56 HEARING AIDS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 57 HEARING AIDS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.3 BLOOD PRESSURE MONITORS
                    6.3.3.1 Increasing number of patients with hypertension and amplified occurrence of cardiovascular diseases to drive the market growth
                                TABLE 58 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 59 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.4 ECG/EKG DEVICES
                    6.3.4.1 High prevalence of cardiovascular diseases to drive the market
                                TABLE 60 ECG/EKG DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 61 ECG/EKG DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.5 OVULATION & PREGNANCY TEST KITS
                    6.3.5.1 Privacy, convenience, accessibility, and quick results to drive the market for ovulation and pregnancy test kits
                                TABLE 62 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION,  2018–2020 (USD MILLION)
                                TABLE 63 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.6 PULSE OXIMETERS
                    6.3.6.1 Pulse oximeters are used to measure oxygen saturation  in the blood
                                TABLE 64 PULSE OXIMETERS OFFERED BY MAJOR PLAYERS
                                TABLE 65 PULSE OXIMETERS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 66 PULSE OXIMETERS MARKET, BY REGION, 2021–2026 (USD MILLION )
           6.3.7 HEART RATE MONITORS
                    6.3.7.1 Ability to continuously monitor critical cardiac parameters to drive the demand for heart rate monitors
                                TABLE 67 HEART RATE MONITORS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 68 HEART RATE MONITORS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.8 COAGULATION MONITORING PRODUCTS
                    6.3.8.1 Coagulation monitors are used for routine management of prothrombin time/international normalized ratio for  safe and effective management
                                TABLE 69 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 70 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.9 FETAL MONITORING DEVICES
                    6.3.9.1 Remote-based care by por                                TABLE fetal monitoring systems to drive market growth
                                TABLE 71 FETAL MONITORING DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 72 FETAL MONITORING DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.10 HIV TEST KITS
                    6.3.10.1 Rising prevalence of HIV to drive the market
                                TABLE 73 HIV TEST KITS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 74 HIV TEST KITS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.11 HOLTER & EVENT MONITORS
                    6.3.11.1 Rising awareness of preventive care and technological advancements to drive the market
                                TABLE 75 HOLTER & EVENT MONITORS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 76 HOLTER & EVENT MONITORS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.12 TEMPERATURE MONITORING DEVICES
                    6.3.12.1 Technological innovations and increasing awareness on the use of temperature monitoring devices for personal care to drive market growth
                                TABLE 77 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 78 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.13 CHOLESTEROL TESTING PRODUCTS
                    6.3.13.1 Rising obesity levels and the incidence of cardiovascular disorders are supporting market growth
                                TABLE 79 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 80 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.14 DRUG & ALCOHOL TEST KITS
                    6.3.14.1 Rising consumption of drugs among teens to support market growth
                                TABLE 81 RECENT APPROVALS FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES
                                TABLE 82 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 83 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.15 PEAK FLOW METERS
                    6.3.15.1 Peak flow meters are used to monitor a person’s ability to breathe
                                TABLE 84 PEAK FLOW METERS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 85 PEAK FLOW METERS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.16 COLON CANCER TEST KITS
                    6.3.16.1 High incidence of colorectal cancer to drive the market growth
                                TABLE 86 COLON CANCER TEST KITS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 87 COLON CANCER TEST KITS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.17 ACTIVITY MONITORS & WRIST BANDS
                    6.3.17.1 Increasing prevalence of chronic diseases has resulted in a significant increase in the demand for activity monitors
                                TABLE 88 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 89 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.18 EEG DEVICES
                    6.3.18.1 Emergence of epilepsy as a common neurological condition to drive the market for EEG devices
                                TABLE 90 EEG DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 91 EEG DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.19 HOME SLEEP TESTING DEVICES
                    6.3.19.1 Cost-effectiveness of home-based sleep tests to fuel the growth of home sleep testing devices
                                TABLE 92 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 93 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.3.20 HOME HEMOGLOBIN A1C TEST KITS
                    6.3.20.1 High incidence of diabetes to drive market growth
                                TABLE 94 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 95 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION, 2021–2026 (USD MILLION)
    6.4 MOBILITY CARE PRODUCTS
          TABLE 96 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 97 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 98 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY REGION,  2018–2020 (USD MILLION)
          TABLE 99 HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY REGION,  2021–2026 (USD MILLION)
           6.4.1 WHEELCHAIRS
                    6.4.1.1 Increased preference for wheelchairs to support  market growth
                                TABLE 100 WHEELCHAIRS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 101 WHEELCHAIRS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.4.2 MOBILITY SCOOTERS
                    6.4.2.1 Mobility scooters help users to travel long distances
                                TABLE 102 MOBILITY SCOOTERS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 103 MOBILITY SCOOTERS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.4.3 WALKERS & ROLLATORS
                    6.4.3.1 Walkers are used by the disabled and the elderly for additional support while walking
                                TABLE 104 WALKERS AND ROLLATORS MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 105 WALKERS AND ROLLATORS MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.4.4 CRUTCHES
                    6.4.4.1 Axilla crutches are the most preferred as they are easy to use and are often used by people who have a temporary injury
                                TABLE 106 CRUTCHES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 107 CRUTCHES MARKET, BY REGION, 2021–2026 (USD MILLION)
           6.4.5 CANES
                    6.4.5.1 Canes are the most common assistive devices
                                TABLE 108 CANES MARKET, BY REGION, 2018–2020 (USD MILLION)
                                TABLE 109 CANES MARKET, BY REGION, 2021–2026 (USD MILLION)

7 HOME HEALTHCARE MARKET, BY SERVICE (Page No. - 171)
    7.1 INTRODUCTION
          TABLE 110 US: AVERAGE SENIOR CARE COST, BY TYPE AND DURATION, 2019
          TABLE 111 HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD BILLION)
          TABLE 112 HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD BILLION)
          TABLE 113 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2018–2020 (USD BILLION)
          TABLE 114 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2021–2026 (USD BILLION)
    7.2 SKILLED NURSING
           7.2.1 SKILLED NURSING SERVICES TO DOMINATE THE HOME HEALTHCARE SERVICES MARKET DURING THE FORECAST PERIOD
                    TABLE 115 SKILLED NURSING SERVICES MARKET, BY REGION, 2018–2020 (USD BILLION)
                    TABLE 116 SKILLED NURSING SERVICES MARKET, BY REGION, 2021–2026 (USD BILLION)
    7.3 REHABILITATION THERAPY
           7.3.1 REHABILITATION THERAPY SERVICES MAJORLY INCLUDE PHYSIOTHERAPY, OCCUPATIONAL THERAPY, AND SPEECH THERAPY
                    TABLE 117 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2018–2020 (USD BILLION)
                    TABLE 118 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2021–2026 (USD BILLION)
    7.4 HOSPICE & PALLIATIVE CARE
           7.4.1 RISING GERIATRIC POPULATION TO DRIVE HOSPICE & PALLIATIVE CARE SERVICES
                    TABLE 119 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2018–2020 (USD BILLION)
                    TABLE 120 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2021–2026 (USD BILLION)
    7.5 UNSKILLED CARE
           7.5.1 UNSKILLED CARE SERVICES ARE COST-EFFECTIVE AND OFFER COMFORT AND SECURITY TO PATIENTS
                    TABLE 121 UNSKILLED CARE SERVICES MARKET, BY REGION, 2018–2020 (USD BILLION)
                    TABLE 122 UNSKILLED CARE SERVICES MARKET, BY REGION, 2021–2026 (USD BILLION)
    7.6 RESPIRATORY THERAPY
           7.6.1 GROWING PREVALENCE OF RESPIRATORY DISORDERS  TO DRIVE MARKET GROWTH
                    TABLE 123 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2018–2020 (USD BILLION)
                    TABLE 124 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2021–2026 (USD BILLION)
    7.7 INFUSION THERAPY
           7.7.1 HOME INFUSION IS A SAFE AND EFFECTIVE ALTERNATIVE TO IN-PATIENT CARE FOR VARIOUS DISEASE STATES AND THERAPIES
                    TABLE 125 INFUSION THERAPY SERVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                    TABLE 126 INFUSION THERAPY SERVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
    7.8 PREGNANCY CARE
           7.8.1 PREGNANCY CARE SERVICES HELP EXPECTANT PARENTS TO MANAGE HIGH-RISK PREGNANCIES AND COMPLICATIONS
                    TABLE 127 PREGNANCY CARE SERVICES MARKET, BY REGION, 2018–2020 (USD MILLION)
                    TABLE 128 PREGNANCY CARE SERVICES MARKET, BY REGION, 2021–2026 (USD MILLION)

8 HOME HEALTHCARE MARKET, BY INDICATION (Page No. - 185)
    8.1 INTRODUCTION
          TABLE 129 HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD BILLION)
          TABLE 130 HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD BILLION)
    8.2 CANCER
           8.2.1 HIGH PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
                    TABLE 131 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
                    TABLE 132 PROJECTED INCREASE IN THE GLOBAL NUMBER OF CANCER PATIENTS,  2015 VS. 2018 VS. 2035
                    TABLE 133 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2018–2020 (USD BILLION)
                    TABLE 134 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2021–2026 (USD BILLION)
    8.3 RESPIRATORY DISEASES
           8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES IS A KEY FACTOR DRIVING MARKET GROWTH
                    TABLE 135 INCIDENCE OF TB, 2019
                    TABLE 136 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION,   2018–2020 (USD BILLION)
                    TABLE 137 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION,   2021–2026 (USD BILLION)
    8.4 MOVEMENT DISORDERS
           8.4.1 AGING IS A RISK FACTOR FOR MOVEMENT DISORDERS
                    TABLE 138 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION,   2018–2020 (USD BILLION)
                    TABLE 139 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION,   2021–2026 (USD BILLION)
    8.5 CARDIOVASCULAR DISEASES & HYPERTENSION
           8.5.1 RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE THE GROWTH OF THIS SEGMENT
                    TABLE 140 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION,  BY REGION, 2018–2020 (USD BILLION)
                    TABLE 141 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISEASES & HYPERTENSION,  BY REGION, 2021–2026 (USD BILLION)
    8.6 PREGNANCY
           8.6.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH
                    TABLE 142 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2018–2020 (USD BILLION)
                    TABLE 143 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2021–2026 (USD BILLION)
    8.7 WOUND CARE
           8.7.1 GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET GROWTH
                    TABLE 144 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2018–2020 (USD BILLION)
                    TABLE 145 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2021–2026 (USD BILLION)
    8.8 DIABETES
           8.8.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH
                    TABLE 146 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2018–2020 (USD BILLION)
                    TABLE 147 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2021–2026 (USD BILLION)
    8.9 HEARING DISORDERS
           8.9.1 PREVALENCE OF HEARING LOSS IS HIGHER IN THE AGING POPULATION
                    TABLE 148 GLOBAL INCIDENCE OF HEARING DISORDERS
                    TABLE 149 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION,   2018–2020 (USD BILLION)
                    TABLE 150 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION,   2021–2026 (USD BILLION)
    8.10 OTHER INDICATIONS
           TABLE 151 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2018–2020 (USD BILLION)
           TABLE 152 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION,  2021–2026 (USD BILLION)

9 HOME HEALTHCARE MARKET, BY REGION (Page No. - 201)
    9.1 INTRODUCTION
          TABLE 153 HOME HEALTHCARE MARKET, BY REGION, 2018–2020 (USD BILLION)
          TABLE 154 HOME HEALTHCARE MARKET, BY REGION, 2021–2026 (USD BILLION)
    9.2 NORTH AMERICA
          FIGURE 35 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT
          TABLE 155 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2018–2020 (USD BILLION)
          TABLE 156 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2026 (USD BILLION)
          TABLE 157 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD BILLION)
          TABLE 158 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD BILLION)
          TABLE 159 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 160 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 161 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 162 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 163 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
          TABLE 164 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 165 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
          TABLE 166 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 167 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 168 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 169 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION,  2018–2020 (USD MILLION)
          TABLE 170 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION,  2021–2026 (USD MILLION)
           9.2.1 US
                    9.2.1.1 The US dominates the North American home healthcare market
                                TABLE 171 US: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD BILLION)
                                TABLE 172 US: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD BILLION)
                                TABLE 173 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 174 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 175 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 176 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 177 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 178 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 179 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 180 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 181 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 182 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 183 US: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                                TABLE 184 US: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising geriatric population in the country to drive market growth
                                TABLE 185 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 186 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 187 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 188 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 189 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 190 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 191 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 192 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 193 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 194 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 195 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 196 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 197 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                                TABLE 198 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
    9.3 EUROPE
          TABLE 199 EUROPE: PERCENTAGE OF POPULATION AGED 60 AND OVER, 2017 VS. 2050
          TABLE 200 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION, 2018–2020 (USD BILLION)
          TABLE 201 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION, 2021–2026 (USD BILLION)
          TABLE 202 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 203 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 204 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 205 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 206 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 207 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 208 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
          TABLE 209 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 210 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
          TABLE 211 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 212 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 213 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 214 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
          TABLE 215 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany to dominate the European home healthcare market
                                TABLE 216 GERMANY: KEY MACROINDICATORS
                                TABLE 217 GERMANY: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 218 GERMANY: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 219 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 220 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 221 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 222 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 223 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 224 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 225 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 226 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 227 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 228 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 229 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                                TABLE 230 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.3.2 FRANCE
                    9.3.2.1 Government support and initiatives taken by market players to drive the home healthcare market
                                TABLE 231 FRANCE: KEY INDICATORS
                                TABLE 232 FRANCE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 233 FRANCE: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 234 FRANCE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 235 FRANCE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 236 FRANCE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 237 FRANCE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 238 FRANCE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 239 FRANCE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 240 FRANCE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 241 FRANCE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 242 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 243 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 244 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                                TABLE 245 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 High burden of chronic diseases to drive the market in the country
                                TABLE 246 UK: KEY MACROINDICATORS
                                TABLE 247 UK: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 248 UK: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 249 UK: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 250 UK: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 251 UK: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 252 UK: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 253 UK: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 254 UK: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 255 UK: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 256 UK: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 257 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 258 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 259 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                                TABLE 260 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Rising geriatric population and the favorable government policy to drive the market in the country
                                TABLE 261 ITALY: KEY INDICATORS
                                TABLE 262 ITALY: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 263 ITALY: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 264 ITALY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 265 ITALY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 266 ITALY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 267 ITALY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 268 ITALY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 269 ITALY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 270 ITALY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 271 ITALY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 272 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 273 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 274 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                                TABLE 275 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Rising geriatric population and the increasing incidence of chronic conditions to drive market growth
                                TABLE 276 SPAIN: KEY INDICATORS
                                TABLE 277 SPAIN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 278 SPAIN: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 279 SPAIN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 280 SPAIN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 281 SPAIN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 282 SPAIN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 283 SPAIN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 284 SPAIN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 285 SPAIN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 286 SPAIN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 287 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 288 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 289 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                                TABLE 290 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 291 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP)
                    TABLE 292 ROE: PERCENTAGE OF POPULATION AGED 60 AND OVER, 2017 VS. 2050
                    TABLE 293 ROE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                    TABLE 294 ROE: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                    TABLE 295 ROE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                    TABLE 296 ROE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                    TABLE 297 ROE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                    TABLE 298 ROE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                    TABLE 299 ROE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                    TABLE 300 ROE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                    TABLE 301 ROE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                    TABLE 302 ROE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                    TABLE 303 ROE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                    TABLE 304 ROE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                    TABLE 305 ROE: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                    TABLE 306 ROE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
    9.4 ASIA PACIFIC
          FIGURE 36 ASIA PACIFIC: HOME HEALTHCARE MARKET SNAPSHOT
          TABLE 307 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2018–2020 (USD BILLION)
          TABLE 308 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2026 (USD BILLION)
          TABLE 309 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 310 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 311 ASIA PACIFIC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 312 ASIA PACIFIC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 313 ASIA PACIFIC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 314 ASIA PACIFIC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 315 ASIA PACIFIC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
          TABLE 316 ASIA PACIFIC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 317 ASIA PACIFIC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
          TABLE 318 ASIA PACIFIC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 319 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 320 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 321 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
          TABLE 322 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Growing geriatric population in the country to drive the home healthcare market
                                TABLE 323 JAPAN: KEY INDICATORS
                                TABLE 324 JAPAN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 325 JAPAN: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 326 JAPAN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 327 JAPAN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 328 JAPAN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 329 JAPAN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 330 JAPAN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 331 JAPAN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 332 JAPAN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 333 JAPAN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 334 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 335 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 336 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                                TABLE 337 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Healthcare development and reforms will drive the market  in the country
                                TABLE 338 CHINA: KEY INDICATORS
                                TABLE 339 CHINA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 340 CHINA: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 341 CHINA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 342 CHINA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 343 CHINA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 344 CHINA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 345 CHINA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 346 CHINA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 347 CHINA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 348 CHINA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 349 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 350 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 351 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                                TABLE 352 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Increasing target patient population to drive the market  in the country
                                TABLE 353 INDIA: KEY INDICATORS
                                TABLE 354 INDIA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 355 INDIA: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 356 INDIA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 357 INDIA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 358 INDIA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 359 INDIA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 360 INDIA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 361 INDIA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 362 INDIA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                                TABLE 363 INDIA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                                TABLE 364 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                                TABLE 365 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                                TABLE 366 INDIA: HOME HEALTHCARE MARKET, BY INDICATION,  2018–2020 (USD MILLION)
                                TABLE 367 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 368 ROAPAC: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
                    TABLE 369 ROAPAC: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
                    TABLE 370 ROAPAC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                    TABLE 371 ROAPAC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                    TABLE 372 ROAPAC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
                    TABLE 373 ROAPAC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
                    TABLE 374 ROAPAC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                    TABLE 375 ROAPAC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                    TABLE 376 ROAPAC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
                    TABLE 377 ROAPAC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
                    TABLE 378 ROAPAC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
                    TABLE 379 ROAPAC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
                    TABLE 380 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
                    TABLE 381 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)
    9.5 REST OF THE WORLD
          TABLE 382 MEXICO: KEY INDICATORS
          TABLE 383 BRAZIL: KEY INDICATORS
          TABLE 384 ROW: HOME HEALTHCARE MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 385 ROW: HOME HEALTHCARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 386 ROW: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 387 ROW: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 388 ROW: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 389 ROW: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 390 ROW: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
          TABLE 391 ROW: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 392 ROW: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2018–2020 (USD MILLION)
          TABLE 393 ROW: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE,  2021–2026 (USD MILLION)
          TABLE 394 ROW: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2020 (USD MILLION)
          TABLE 395 ROW: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 396 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2020 (USD MILLION)
          TABLE 397 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 339)
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             TABLE 398 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE HOME HEALTHCARE MARKET
     10.3 MARKET SHARE ANALYSIS, 2020
             FIGURE 37 SLEEP APNEA DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
             FIGURE 38 HEARING AIDS MARKET SHARE, BY KEY PLAYER, 2020
     10.4 COMPETITIVE LEADERSHIP MAPPING
             10.4.1 STARS
             10.4.2 EMERGING LEADERS
             10.4.3 PERVASIVE PLAYERS
             10.4.4 PARTICIPANTS
                       FIGURE 39 HOME HEALTHCARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
     10.5 COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS
             10.5.1 PROGRESSIVE COMPANIES
             10.5.2 STARTING BLOCKS
             10.5.3 RESPONSIVE COMPANIES
             10.5.4 DYNAMIC COMPANIES
                       FIGURE 40 HOME HEALTHCARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS (2020)
     10.6 COMPANY FOOTPRINT
             TABLE 399 COMPANY FOOTPRINT
             TABLE 400 COMPANY PRODUCT FOOTPRINT
             TABLE 401 COMPANY REGIONAL FOOTPRINT
     10.7 COMPETITIVE SCENARIO
             10.7.1 PRODUCT LAUNCHES & APPROVALS
                       TABLE 402 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2018–OCTOBER 2021
             10.7.2 DEALS
                       TABLE 403 KEY DEALS, JANUARY 2018–OCTOBER 2021
             10.7.3 OTHER DEVELOPMENTS
                       TABLE 404 OTHER KEY DEVELOPMENTS, JANUARY 2018–OCTOBER 2021

11 COMPANY PROFILES (Page No. - 359)
     11.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Key strengths/right to win, Strategic choices made, and Weaknesses and competitive threats)*
             11.1.1 FRESENIUS SE & CO. KGAA
                       TABLE 405 FRESENIUS SE & CO. KGAA: BUSINESS OVERVIEW
                       FIGURE 41 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2020)
             11.1.2 LINDE PLC
                       TABLE 406 LINDE PLC: BUSINESS OVERVIEW
                       FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2020)
             11.1.3 F. HOFFMANN-LA ROCHE LTD.
                       TABLE 407 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
                       FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
             11.1.4 A&D COMPANY, LIMITED
                       TABLE 408 A&D COMPANY, LIMITED: BUSINESS OVERVIEW
                       FIGURE 44 A&D COMPANY, LIMITED: COMPANY SNAPSHOT (2020)
             11.1.5 BAYADA HOME HEALTH CARE
                       TABLE 409 BAYADA HOME HEALTH CARE: BUSINESS OVERVIEW
             11.1.6 INVACARE CORPORATION
                       TABLE 410 INVACARE CORPORATION: BUSINESS OVERVIEW
                       FIGURE 45 INVACARE CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.7 ABBOTT
                       TABLE 411 ABBOTT: BUSINESS OVERVIEW
                       FIGURE 46 ABBOTT: COMPANY SNAPSHOT (2020)
             11.1.8 AMEDISYS
                       TABLE 412 AMEDISYS: BUSINESS OVERVIEW
                       FIGURE 47 AMEDISYS: COMPANY SNAPSHOT (2020)
             11.1.9 RESMED
                       TABLE 413 RESMED: BUSINESS OVERVIEW
                       FIGURE 48 RESMED: COMPANY SNAPSHOT (2020)
             11.1.10 LHC GROUP, INC.
                        TABLE 414 LHC GROUP, INC.: BUSINESS OVERVIEW
                        FIGURE 49 LHC GROUP, INC.: COMPANY SNAPSHOT (2020)
             11.1.11 OMRON CORPORATION
                        TABLE 415 OMRON CORPORATION: BUSINESS OVERVIEW
                        FIGURE 50 OMRON CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.12 KONINKLIJKE PHILIPS N.V.
                        TABLE 416 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                        FIGURE 51 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
             11.1.13 GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
                        TABLE 417 GENERAL HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 52 GENERAL HEALTHCARE SNAPSHOT: COMPANY SNAPSHOT (2020)
             11.1.14 DRIVE DEVILBISS HEALTHCARE
                        TABLE 418 DRIVE DEVILBISS HEALTHCARE: BUSINESS OVERVIEW
             11.1.15 HAMILTON MEDICAL
                        TABLE 419 HAMILTON MEDICAL: BUSINESS OVERVIEW
     11.2 OTHER PLAYERS
             11.2.1 SUNRISE MEDICAL
             11.2.2 ROMA MEDICAL
             11.2.3 CAREMAX REHABILITATION EQUIPMENT CO., LTD.
             11.2.4 VITALOGRAPH
             11.2.5 ADVITA PFLEGEDIENST GMBH
             11.2.6 RENAFAN GMBH
             11.2.7 ADMR
             11.2.8 APEX MEDICAL CORP.
             11.2.9 CONTEC MEDICAL SYSTEMS CO., LTD.
             11.2.10 LΦWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.

*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths/right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 428)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the home healthcare market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the home healthcare market. The secondary sources used for this study include the World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), Home Care Association of America (HCAOA), Home Care Technology Association of America (HCTAA), American Telemedicine Association, American Heart Association, American Sleep Apnea Association (ASAA), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), United Kingdom Homecare Association (UKHCA), US Department of Veterans Affairs, The National Association for Home Care & Hospice, Alcohol & Drug Information Centre (ADIC), Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Home Healthcare Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the home healthcare market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the home healthcare business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global home healthcare market based on the product, service, indication, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall home healthcare market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the home healthcare market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • An additional five company profiles
COVID-19

Get in-depth analysis of the COVID-19 impact on the Home Healthcare Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Home Healthcare Market

Request For Special Pricing
Report Code
MD 1160
Published ON
Nov, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Home Healthcare Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved